Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tricortin
- Development stage
- Phase 4
- Lead developer
- Fidia Farmaceutici
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Intramuscular
01
Overview
Tricortin is a pharmaceutical preparation containing phospholipids of the cerebral cortex and cyanocobalamin (vitamin B12) in an optimal therapeutic dose[2][7]. It is administered intramuscularly, typically as a 2 ml injection once daily. The drug is indicated for use in conditions such as polymyalgic neurosis syndrome and has also been studied for chronic low back pain[4][7]. Its mechanism of action likely involves neurotrophic support from phospholipids and the hematinic/neurological benefits of vitamin B12, though specific molecular targets are not detailed in available sources. Tricortin can be used during pregnancy and lactation under medical supervision[7].
- Brand names
- Tricortin
- Other names
- Trikortin
02
Targets
MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)
Beyond the preview
Go deeper on Tricortin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tricortin.